Season 1 | Episode 18 | Navigating Drug Pricing, Policy, and Access with Coral Partner Alison Falb

Written By Andrew Petee

Navigating Drug Pricing, Policy, and Access

In this episode, Coral’s Founder Meg Koepke talks with Alison Falb about her journey from CMS to FDA to Coral. We explore current policy trends and challenges in Life Sciences – what they mean for organizations navigating drug pricing reforms, coverage, and access challenges.

 
 
 
Andrew Petee
Previous

Season 1 | Episode 19 | Beyond the Hype: What GLP-1s Mean for Policy and Employers
Next

Season 1 | Episode 17 | Designing Maternity APMs That Work: Lessons from the Field